Shanghai Heartcare Medical Technology Corp. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
93.00
-13.00
-113.00
-193.00
-238.00
-242.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
33.00
-25.00
-27.00
-154.00
-77.00
-8.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
172.00
6.00
-85.00
-291.00
-243.00
-83.00
Cash Flow from Investing Activities
-280.00
1.00
-146.00
22.00
-241.00
-5.00
Cash Flow from Financing Activities
-48.00
-13.00
-23.00
-18.00
1,040.00
771.00
Net Cash Inflow / Outflow
-158.00
-3.00
-254.00
-286.00
555.00
681.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
1.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Heartcare Medical Technology Corp. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
93.7114954174006
1071.04491427128
-978.00
-91.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
33.6332387728501
-413.361744657446
446.00
108.14%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
172.90881456442
560.786429056626
-388.00
-69.17%
Cash Flow from Investing Activities
-280.822143521434
-392.17666513375
112.00
28.39%
Cash Flow from Financing Activities
-48.3795030445656
-146.251230112058
98.00
66.92%
Net Cash Inflow / Outflow
-158.625641772003
21.0690355230284
-179.00
-852.89%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.33280977042437
-1.2894982877892
-1.00
-80.91%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 2,472.63% vs 107.85% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
172.91
6.72
2,472.63%






